RELIDOMIDE 10MG

About

This medication is an immunomodulatory drug with significant anti-angiogenic and anti-neoplastic properties, structurally related to thalidomide but with a distinct pharmacological profile. It exerts its therapeutic effects through multiple mechanisms, including the modulation of the immune system by enhancing T-cell and natural killer (NK) cell activity, inhibiting the production of pro-inflammatory cytokines like TNF-α, and directly inhibiting tumor cell proliferation and inducing apoptosis. Furthermore, it possesses potent anti-angiogenic activity, disrupting the formation of new blood vessels essential for tumor growth. It is primarily indicated for the treatment of multiple myeloma, often in combination with other agents, and certain myelodysplastic syndromes characterized by specific cytogenetic abnormalities. Due to its known teratogenic potential, strict risk management programs, including mandatory contraception, are rigorously enforced for all patients.

Uses

• Treatment of multiple myeloma.
• Myelodysplastic syndromes with specific cytogenetic abnormalities.
• Certain types of lymphoma (off-label).
• Other immune-mediated conditions (investigational).

Directions For Use

Take orally with water, usually once daily. Follow the prescribed dosage and schedule strictly.

Benefits

• Effective in treating multiple myeloma.
• Improves response rates in specific MDS.
• Modulates immune system activity.
• Inhibits tumor growth and angiogenesis.
• Can be used in combination therapies.
• Oral administration offers convenience.

Side Effects

• Thrombosis (blood clots)
• Peripheral neuropathy
• Myelosuppression (low blood counts)
• Fatigue
• Diarrhea
• Constipation
• Rash
• Nausea
• Dizziness
• Muscle cramps
• Tremor
• Teratogenicity (severe birth defects)

Safety Measures

• Alcohol - Avoid or limit alcohol due to potential for increased drowsiness and dizziness.
• Pregnancy - Absolutely contraindicated due to severe teratogenic risk; strict contraception is mandatory for both males and females.
• Breastfeeding - Not recommended due to potential for serious adverse reactions in the infant; discontinue breastfeeding.
• Liver - Use with caution; dose adjustments may be necessary in patients with hepatic impairment.
• Kidney - Dose adjustment is often required based on creatinine clearance; use with caution in renal impairment.
• Lung - Monitor for new or worsening pulmonary symptoms; rare cases of interstitial lung disease reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.